Bio-Rad Laboratories EBITDA Margin 2010-2023 | BIO.B
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bio-Rad Laboratories (BIO.B) over the last 10 years. The current EBITDA margin for Bio-Rad Laboratories as of March 31, 2023 is .
| Bio-Rad Laboratories EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-03-31 |
$2.78B |
$0.40B |
14.32% |
| 2022-12-31 |
$2.80B |
$0.48B |
17.20% |
| 2022-09-30 |
$2.81B |
$0.48B |
17.01% |
| 2022-06-30 |
$2.87B |
$0.54B |
18.84% |
| 2022-03-31 |
$2.90B |
$0.55B |
18.85% |
| 2021-12-31 |
$2.92B |
$0.50B |
17.14% |
| 2021-09-30 |
$2.98B |
$0.57B |
19.09% |
| 2021-06-30 |
$2.88B |
$0.52B |
18.13% |
| 2021-03-31 |
$2.70B |
$0.45B |
16.62% |
| 2020-12-31 |
$2.55B |
$0.42B |
16.58% |
| 2020-09-30 |
$2.38B |
$0.30B |
12.39% |
| 2020-06-30 |
$2.29B |
$0.24B |
10.55% |
| 2020-03-31 |
$2.33B |
$0.25B |
10.56% |
| 2019-12-31 |
$2.31B |
$0.23B |
9.90% |
| 2019-09-30 |
$2.31B |
$-0.06B |
-2.47% |
| 2019-06-30 |
$2.29B |
$-0.04B |
-1.88% |
| 2019-03-31 |
$2.29B |
$-0.06B |
-2.40% |
| 2018-12-31 |
$2.29B |
$-0.07B |
-2.97% |
| 2018-09-30 |
$2.29B |
$0.22B |
9.37% |
| 2018-06-30 |
$2.28B |
$0.22B |
9.55% |
| 2018-03-31 |
$2.21B |
$0.21B |
9.45% |
| 2017-12-31 |
$2.16B |
$0.23B |
10.42% |
| 2017-09-30 |
$2.11B |
$0.15B |
7.01% |
| 2017-06-30 |
$2.09B |
$0.14B |
6.76% |
| 2017-03-31 |
$2.10B |
$0.17B |
7.92% |
| 2016-12-31 |
$2.07B |
$0.17B |
8.03% |
| 2016-09-30 |
$2.07B |
$0.25B |
11.90% |
| 2016-06-30 |
$2.03B |
$0.21B |
10.45% |
| 2016-03-31 |
$2.02B |
$0.19B |
9.51% |
| 2015-12-31 |
$2.02B |
$0.17B |
8.22% |
| 2015-09-30 |
$2.05B |
$0.16B |
7.72% |
| 2015-06-30 |
$2.11B |
$0.16B |
7.50% |
| 2015-03-31 |
$2.14B |
$0.16B |
7.67% |
| 2014-12-31 |
$2.18B |
$0.15B |
6.90% |
| 2014-09-30 |
$2.18B |
$0.15B |
6.93% |
| 2014-06-30 |
$2.15B |
$0.15B |
6.82% |
| 2014-03-31 |
$2.14B |
$0.15B |
7.19% |
| 2013-12-31 |
$2.13B |
$0.17B |
7.92% |
| 2013-09-30 |
$2.10B |
$0.19B |
8.94% |
| 2013-06-30 |
$2.10B |
$0.23B |
10.72% |
| 2013-03-31 |
$2.08B |
$0.25B |
11.76% |
| 2012-12-31 |
$2.07B |
$0.26B |
12.76% |
| 2012-09-30 |
$2.05B |
$0.29B |
14.13% |
| 2012-06-30 |
$2.06B |
$0.30B |
14.40% |
| 2012-03-31 |
$2.08B |
$0.29B |
14.07% |
| 2011-12-31 |
$2.07B |
$0.31B |
14.71% |
| 2011-09-30 |
$2.06B |
$0.29B |
13.95% |
| 2011-06-30 |
$2.01B |
$0.29B |
14.31% |
| 2011-03-31 |
$1.96B |
$0.29B |
14.70% |
| 2010-12-31 |
$1.93B |
$0.28B |
14.73% |
| 2010-09-30 |
$1.89B |
$0.26B |
13.87% |
| 2010-06-30 |
$1.88B |
$0.25B |
13.53% |
| 2010-03-31 |
$1.84B |
$0.24B |
13.17% |
| 2009-12-31 |
$1.78B |
$0.23B |
12.89% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.071B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
